Publications by authors named "Deborah Falk"

Claim this Profile
P
Postinjection delirium/sedation syndrome in patients with schizophrenia receiving olanzapine long-acting injection: results from a large observational study.
Kristin J Meyers, Himanshu P Upadhyaya, John L Landry, Rashna Chhabra-Khanna, Deborah M Falk

BJPsych Open· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olanzapine long-acting injection: a review of first experiences of post-injection delirium/sedation syndrome in routine clinical practice.
Chris J Bushe, Deborah Falk, Ernie Anand, Marta Casillas, Elena Perrin

BMC Psychiatry· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olanzapine in pregnancy and breastfeeding: a review of data from global safety surveillance.
Elizabeth Brunner, Deborah M Falk, Meghan Jones, Debashish K Dey, Chetan Chinmaya Shatapathy

BMC Pharmacol Toxicol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitation.
Stephen R Marder, Sebastian Sorsaburu, Eduardo Dunayevich, Jamie L Karagianis, Ian C Dawe, Deborah M Falk

J Clin Psychiatry· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A double-blind, randomized trial to evaluate the pharmacokinetics and tolerability of 30 or 40 mg/d oral olanzapine relative to 20 mg/d oral olanzapine in stable psychiatric subjects.
Malcolm Mitchell, Robert Riesenberg, Mohammad A Bari, Eva Marquez, Darcie Kurtz, Deborah Falk

Clin Ther· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis